Samantha

Equibles does not estimate personal net worth.

Get an email with a short summary when Axsome Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get AXSM alerts

About Samantha

Samantha has spoken on 1 earnings call across 1 company, most recently for Axsome Therapeutics, Inc. on November 2, 2026. Axsome Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Axsome Therapeutics, Inc. includes Herriot Tabuteau (CEO), Nick Pizzie (CFO), Mark Jacobson (COO) and 4 others.

Samantha on recent calls

“For AXS-12 or Raboxetine, with the first approval of an Erexin-2 receptor agonist, how are you thinking about the underlying commercial opportunity for Raboxetine in the narcolepsy market?”

Other, Axsome Third Quarter 2026 Financial Results · November 2, 2026